Statements (44)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:DJ
|
| gptkbp:bfsLayer |
8
|
| gptkbp:bfsParent |
gptkb:Muscular_Dystrophy
|
| gptkbp:affects |
skeletal muscles
|
| gptkbp:associated_with |
gptkb:hospital
scoliosis joint contractures |
| gptkbp:caused_by |
mutation in the dystrophin gene
|
| gptkbp:clinical_trial |
ongoing
|
| gptkbp:current_use |
gptkb:Duchenne_muscular_dystrophy
|
| gptkbp:descendant |
X-linked recessive
|
| gptkbp:first_described_by |
Peter Emil Becker
|
| gptkbp:genetic_diversity |
recommended
|
| gptkbp:gestation_period |
important consideration
|
| gptkbp:habitat |
Xp21.1
|
| https://www.w3.org/2000/01/rdf-schema#label |
Becker Muscular Dystrophy
|
| gptkbp:is_involved_in |
gptkb:stock_market_index
|
| gptkbp:is_popular_in |
1 in 20,000 males
|
| gptkbp:lifespan |
normal or near normal
|
| gptkbp:notable_event |
notable individuals
|
| gptkbp:number_of_teams |
slower than Duchenne muscular dystrophy
|
| gptkbp:premiered_on |
childhood or adolescence
|
| gptkbp:public_awareness |
September
|
| gptkbp:research_focus |
gptkb:physicist
stem cell therapy exon skipping dystrophin replacement therapy |
| gptkbp:scholarships |
gptkb:Educational_Institution
psychological counseling community support advocacy organizations peer support |
| gptkbp:social_responsibility |
genetic testing
muscle biopsy electromyography |
| gptkbp:subject |
biomarkers
muscle regeneration clinical outcomes quality of life studies |
| gptkbp:symptoms |
muscle weakness
muscle wasting |
| gptkbp:treatment |
gptkb:hospital
medications physical therapy |